Sep 22, 2026 04:05PM
May 13, 2026 04:05PM
Feb 3, 2026 04:05PM
Jan 20, 2026 04:05PM
Jan 20, 2026 09:01AM
Jan 20, 2026 09:00AM
Dec 10, 2025 03:55AM Aytu Biosciences (AYTU) PT Raised to $13 at Ascendiant Capital
Nov 13, 2025 04:05PM
Oct 28, 2025 09:01AM
Oct 28, 2025 09:00AM
Sep 23, 2025 04:05PM
Jun 30, 2025 03:25AM
Jun 25, 2025 08:00AM
Jun 23, 2025 08:05AM Aytu BioScience (AYTU) Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA
Jun 23, 2025 08:00AM
Jun 9, 2025 04:30PM
Jun 6, 2025 08:15AM
Jun 6, 2025 08:01AM
Jun 6, 2025 08:01AM
Jun 6, 2025 08:00AM
Oct 1, 2024 12:00PM Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
Oct 1, 2024 08:02AM
Nov 14, 2023 04:18PM
Nov 14, 2023 04:05PM
Oct 26, 2023 08:05AM
Oct 26, 2023 08:00AM
Sep 27, 2023 04:22PM
Sep 26, 2023 08:27PM Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023
Jul 10, 2023 08:02AM
Jul 10, 2023 08:00AM
May 11, 2023 04:05PM
May 1, 2023 08:02AM
May 1, 2023 08:00AM
Apr 27, 2023 08:01AM
Apr 27, 2023 08:00AM Aytu BioPharma Announces Approval of Adzenys XR-ODT(R)Manufacturing Site Transfer
Jan 10, 2023 08:03AM
Jan 10, 2023 08:00AM
Nov 30, 2022 08:00AM
Oct 5, 2022 08:02AM
Oct 5, 2022 08:00AM
Sep 27, 2022 04:05PM
Sep 20, 2022 08:00AM Aytu BioPharma to Report Fourth Quarter and Fiscal 2022 Financial Results on September 27, 2022
Sep 14, 2022 08:04AM
Sep 14, 2022 08:00AM
Aug 24, 2022 08:00AM
Aug 16, 2022 08:04AM
Aug 16, 2022 08:00AM
Aug 15, 2022 04:01PM
Aug 9, 2022 09:17AM Aytu BioScience (AYTU) Prices Public Offering of Common Stock, Warrants
Aug 9, 2022 09:15AM

334,274 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All